Literature DB >> 30714418

Prevalence of Comorbid Chronic Obstructive Pulmonary Disease in Individuals Suffering from Schizophrenia and Bipolar Disorder: A Systematic Review.

Nicholas Zareifopoulos1, Aggeliki Bellou1, Agathi Spiropoulou1, Kostas Spiropoulos1.   

Abstract

The disease burden associated with schizophrenia and bipolar disorder is substantial, with affected individuals having a shorter life expectancy and a high risk of severe physical comorbid conditions. These individuals are more likely to smoke and have a longer smoking history compared to the general population. Furthermore, use of antipsychotic drugs has also been linked to active smoking. Chronic obstructive pulmonary disease (COPD) is a respiratory condition affecting elderly individuals with a long smoking history, so it would be expected that individuals suffering from major mental disorders may exhibit a higher prevalence of COPD compared to the general population. We searched the databases Pubmed and Scopus for observational studies of at least 200 patients including at least one group suffering from schizophrenia or bipolar disorder and a comparison group of individuals at risk of COPD. The initial search, along with the data extraction process and the risk of bias assessment were carried out independently by the two reviewers. Eight studies were included. The risk of bias was substantial as most studies did not adequately address confounding variables. A pooled analysis showed a greater likelihood of suffering from comorbid COPD compared with the general population both for schizophrenic (OR 1.573, 1.439-1.720) and bipolar individuals (OR 1.551, 1.452-1.658). Based on these findings, COPD is more common in individuals suffering from major mental illness compared to the general population. Further research is required to ascertain whether smoking is the only cause and develop strategies for the prevention of COPD in these high-risk groups.

Entities:  

Keywords:  Bipolar disorder; COPD; Schizophrenia; Smoking; mental health

Mesh:

Year:  2019        PMID: 30714418     DOI: 10.1080/15412555.2019.1572730

Source DB:  PubMed          Journal:  COPD        ISSN: 1541-2563            Impact factor:   2.409


  7 in total

1.  Novel disease associations with schizophrenia genetic risk revealed in ~400,000 UK Biobank participants.

Authors:  Ruyue Zhang; Arvid Sjölander; Alexander Ploner; Donghao Lu; Cynthia M Bulik; Sarah E Bergen
Journal:  Mol Psychiatry       Date:  2021-11-19       Impact factor: 13.437

2.  Psychological symptoms during and after Austrian first lockdown in individuals with bipolar disorder? A follow-up control-group investigation.

Authors:  Nina Dalkner; Jolana Wagner-Skacel; Michaela Ratzenhofer; Frederike Fellendorf; Melanie Lenger; Alexander Maget; Adelina Tmava-Berisha; René Pilz; Robert Queissner; Carlo Hamm; Susanne Bengesser; Martina Platzer; Armin Birner; Eva Reininghaus
Journal:  Int J Bipolar Disord       Date:  2021-06-01

3.  COVID-19 in People With Schizophrenia: Potential Mechanisms Linking Schizophrenia to Poor Prognosis.

Authors:  Mohapradeep Mohan; Benjamin Ian Perry; Ponnusamy Saravanan; Swaran Preet Singh
Journal:  Front Psychiatry       Date:  2021-05-17       Impact factor: 4.157

4.  Chronic obstructive pulmonary disease in severe mental illness: A timely diagnosis to advance the process of quitting smoking.

Authors:  M J Jaen-Moreno; N Feu; G I Del Pozo; C Gómez; L Carrión; G M Chauca; I Guler; F J Montiel; M D Sánchez; J A Alcalá; L Gutierrez-Rojas; V Molina; J Bobes; V Balanzá-Martínez; C Ruiz-Rull; F Sarramea
Journal:  Eur Psychiatry       Date:  2021-02-26       Impact factor: 5.361

5.  Analysis of COVID-19 Infection and Mortality Among Patients With Psychiatric Disorders, 2020.

Authors:  Antonio L Teixeira; Trudy Millard Krause; Lopita Ghosh; Lokesh Shahani; Rodrigo Machado-Vieira; Scott D Lane; Eric Boerwinkle; Jair C Soares
Journal:  JAMA Netw Open       Date:  2021-11-01

6.  Primary care for people with severe mental illness and comorbid obstructive airways disease: a qualitative study of patient perspectives with integrated stakeholder feedback.

Authors:  Caroline Mitchell; Nicholas Zuraw; Brigitte Delaney; Helen Twohig; Neil Dolan; Elizabeth Walton; Joe Hulin; Camelia Yousefpour
Journal:  BMJ Open       Date:  2022-03-01       Impact factor: 2.692

Review 7.  Schizophrenia and COVID-19: risks and recommendations.

Authors:  Lais Fonseca; Elton Diniz; Guilherme Mendonça; Fernando Malinowski; Jair Mari; Ary Gadelha
Journal:  Braz J Psychiatry       Date:  2020-04-09       Impact factor: 2.697

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.